Instil Bio, Inc.

US$6.83As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TILHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (53.52%)
Div yield —
ROE (25.33%)
Biotechnology
Beta (5Y) 1.96
PE TTM —
TSR TTM (61.28%)
Mkt cap US$46.32M
ROIC (11.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.33
21.91%
(30.68%)
Hold 9|5|8|1|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.08
0.08
0.08
0.09
2.77%
7.56%
5.10%
14.14%
Revenue$M
3.831
4.013
4.147
4.078
1.12%
6.85%
8.11%
9.03%
Peers (US$46.32M)
Cap (US$)
PE
46.60M
—
Capital
TTM
5Y
10Y
Leveragex
0.115
(0.192)
(0.149)
EBIT/Intx
0.436
0.484
0.421
Own earn%
373.41
(74.32)
(61.98)
Sh yield%
32.83
30.96
29.76
Owners
Insiders/Inst%
11.56
68.64
Short interest%
4.54
SBC / revenue%
4.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
20–25
$1 testx
0.7
Incr. ROIC%
9